Please join us on Wednesday 30th March, 14.00 – 15.00 (BST) to hear Névine Zariffa, ICODA‘s Driver Project 1 Lead & President of the NMD Group, and Jaap Mandema (Chief Innovation Officer, Certara),talk about the work their team has carried out over the last 18 months to conduct a holistic evaluation of the efficacy and safety of treatments of COVID-19. In the presentation we will hear about repurposed drugs that were studied in both randomized clinical trials and observational real-world studies. The team systematically evaluated both types of studies to see if their results aligned or diverged, and what factors might explain the divergence if any. They also evaluate whether an initial methodology for combining both sets of studies can provide us reliable and faster answers about the therapeutic potential of repurposed drugs to treat COVID-19. This is an exciting opportunity to hear the results of this important body of work.